Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Dr. Reddy's Laboratories Ltd ADR
(NY:
RDY
)
83.47
+1.20 (+1.46%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dr. Reddy's Laboratories Ltd ADR
< Previous
1
2
3
4
5
6
Next >
Intercept Surges To Four-Month High After Staving Off Amneal's Generic For 11 Years
January 25, 2023
Intercept entered a deal with Amneal, likely lining up a series of new settlements.
Via
Investor's Business Daily
Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe
January 20, 2023
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Journey Medical Touts Positive PK Data For Bacterial Infection Candidate
December 20, 2022
Via
Benzinga
Dr. Reddy’s Successfully Completes Phase 1 Study of DRL_TC, a Proposed Biosimilar of Tocilizumab
December 19, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Intercept Settles Ocaliva Litigation With Reddy's Lab
August 17, 2022
Via
Benzinga
Novartis Fails To Prevent Generic Competition For Its Blockbuster Multiple Sclerosis Drug
October 14, 2022
The U.S. Supreme Court rejected Novartis AG's (NYSE: NVS) effort to block the launch of generic versions of its multiple sclerosis drug Gilenya.
Via
Benzinga
World Economic Forum Recognises Dr. Reddy’s Hyderabad Factory as Part of its Global Lighthouse Network
October 11, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories Announces the Launch of Lenalidomide Capsules in the U.S. With Two of Six Strengths Eligible for First-to-market, 180-day Exclusivity
September 07, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
India Based Pharma Companies In Race To Buy Athenex, Shares Surge
August 05, 2022
Via
Benzinga
Eton Pharma Shares Tick Higher After Offloading Hospital Products
June 24, 2022
Via
Benzinga
Is Sanofi A Buy, Despite Recent Stumbles?
August 19, 2022
Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
August 05, 2022
Good morning! We're starting off the last day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify® in the U.S.
July 29, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories announces the launch of Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market
July 27, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy’s Announces the First-to-Market Launch of Over-the-Counter, Store-Brand Equivalent of Allegra-D® 24 Hr in the U.S. Market
July 22, 2022
From
Dr. Reddy’s Laboratories Ltd. 500124
Via
Business Wire
Dr. Reddy's Laboratories Announces the Launch of Fesoterodine Fumarate Extended-Release Tablets in the U.S. Market
July 08, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx
July 05, 2022
From
Aurigene Discovery Technologies Limited
Via
Business Wire
Dr. Reddy's Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma
June 24, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. market
June 14, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories Announces the Launch of Pemetrexed for Injection USP, in the U.S. Market
May 27, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Positive Phase 2 Results Of SciSparc's Cannabinoid-Based Drug Candidate May Offer Some New Hope To Tourette Syndrome Patients
May 25, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. announce the launch of Ketorolac Tromethamine Tablets USP, 10 mg in the U.S. market
May 24, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
European Cannabis Q1 2022 Quarterly Update
April 28, 2022
Just like the United States’ state-by-state movement, Europe is moving country-by-country toward providing access to cannabis.
Via
Talk Markets
Dr. Reddy's Laboratories Announces the Launch of Posaconazole Delayed-Release Tablets in the U.S. Market
April 20, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories Announces the Launch of Methylprednisolone Sodium Succinate for Injection, USP in the U.S. Market
April 05, 2022
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories & MediCane Health To Launch Medical Cannabis Products In Germany
April 01, 2022
Dr. Reddy's Laboratories Ltd. (NYSE: RDY) and MediCane Health Inc. announced the launch of its medical cannabis product in Germany.
Via
Benzinga
Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany
April 01, 2022
From
MediCane Health Inc.
Via
Business Wire
Flood Helping Ukraine
March 24, 2022
Emerging markets are gaining as mature markets look risky.
Via
Talk Markets
Up On Bad News
March 22, 2022
Despite the plane crash in China, Boeing's stock is up today.
Via
Talk Markets
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.